Veritable, L.P.
- SEC CIK
- 0001300311
- Latest filing
- Nov 14, 2023
VIRX holding history
Viracta Therapeutics, Inc. in every 13F filed by Veritable, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VIRX overviewAll 13F holders of VIRXFull Q3 2023 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −24,836−100.0% | Sold out | Holders |
| Q4 2022 | 24,836 | $36.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 24,836 | $106.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 24,836 | $96.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 24,836 | $118.0K | <0.1% | +24,836 | New | Holders |